Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
AVI BioPharma, Inc. Presenting at Rodman & Renshaw Global Investment Conference
AVI BioPharma, 09/03/09
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA–based drugs, announced that Leslie Hudson, Ph.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference taking place Sept.2009 in New York.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien plc to Report First-Quarter Results on January 2010
Covidien, 12/17/09
ONC to Explain Community I.T. Project
HealthDataManagement, 12/17/09
MediGene AG presents future business plan at annual analyst conference
MediGene, 12/16/09
Article Search
Sponsor


See Latest Articles


